Veterinary Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The Veterinary Molecular Diagnostics Market has witnessed substantial growth in recent years, and the trajectory continues to rise. According to the latest market research, the global revenue from the Veterinary Molecular Diagnostics Market reached approximately US$ 199 Million in 2024, and aiming to reach a valuation of approximately US$ 407 Million by the end of 2031.

The Veterinary Diagnostic Market, an emerging industry known for its technologically advanced diagnostic products and solutions, plays a crucial role in screening various diseases in both pet and farm animals. Several factors are driving this market's growth, including increased consumption of meat and milk products, the introduction of new diseases in animals, and the transmission of infectious diseases from animals to humans, such as Anthrax and Plague.

Greater Precision and Reliability with Molecular Tests

One of the key drivers for the growth of the Veterinary Molecular Diagnostics Market is the preference for molecular diagnostic kits among veterinary physicians. These kits offer unparalleled accuracy, precision, and reliability in diagnostic testing. DNA/RNA-based tests, in particular, have proven to be highly specific and provide reliable results, with a remarkable 99.0% accuracy rate. Moreover, these tests offer reproducibility, sensitivity, and fast pathogen detection, often taking only around 1.5 hours to yield results. The testing process is streamlined, featuring a simple automated workflow with minimal sample handling, thereby minimizing the risk of cross-contamination. The approval of FDA-licensed diagnostic solutions, such as the BIOFIRE Blood Culture Identification 2 (BCID2) Panel in April 2019, further boosts confidence in these diagnostic tools.

Challenges in Market Growth: Knowledge Gaps and Veterinary Services

While the Veterinary Molecular Diagnostics Market shows immense promise, there are challenges that could hinder its growth. A significant knowledge gap in understanding the epidemiology of endemic veterinary diseases remains a key barrier to global market expansion. For example, the lack of comprehensive knowledge about Newcastle Disease outbreaks in chicken and other species has resulted in substantial economic losses. Accelerated mutations in various virulent veterinary diseases have further contributed to these knowledge gaps.

United States Leads the Charge

The United States is at the forefront of the Veterinary Molecular Diagnostics Market. With a high consumption of meat, milk, and eggs, as well as a significant population of pets and farm animals, rigorous diagnostic screening is essential. For instance, pneumonia affects approximately 80% of the hog meat consumed worldwide, according to the World Animal Foundation. Furthermore, zoonotic outbreaks like Salmonella were common in the United States in 2021, impacting chicken and beef. The continued advancement of diagnostic techniques, particularly RT-PCR, is expected to fuel the growth of the veterinary molecular diagnostics market in the United States during the forecast period.

Germany: A Lucrative Market for Veterinary Diagnostics

Germany, known for its high meat consumption, is another promising market for veterinary diagnostics. Animals used in food production often carry pathogens, including non-Typhi serotypes of Salmonella enterics, Shiga toxin-producing strains of Escherichia coli (STEC), and Campylobacter species. As food safety becomes increasingly important, the demand for accurate and efficient diagnostics in the country is set to grow.

China Emerges as a Prominent Market

China, despite a historically low pet adoption rate, has witnessed a surge in pet ownership since the COVID-19 pandemic. Cats and dogs, known for their strong bonds with humans, provide mutual psychosocial health benefits. This growing trend in pet ownership is contributing to the emergence of China as a prominent market in the Veterinary Molecular Diagnostics sector.

Competitive Landscape Analysis

In this dynamic market, key players are employing various strategies to stay competitive. These strategies include partnership agreements between manufacturers and suppliers, targeted product marketing campaigns to capture maximum market share, and responsive manufacturing to meet immediate demands, especially during the spread of contagious diseases like strep throat, colds, and flu.

Key Companies Covered:

bioMerieux SA
IDEXX Laboratories, Inc.
Thermo Fisher Scientific Inc.
Qiagen N.V.
Neogen Corporation
ID. Vet
INDICAL BIOSCIENCE GmbH
Veterinary Molecular Diagnostics, Inc.

The Veterinary Molecular Diagnostics Market is on a growth trajectory, driven by the demand for precise and reliable diagnostic solutions in the animal healthcare industry. With technological advancements and increased awareness of the importance of animal health, this market is poised for a promising future.

Key Segments Covered in Veterinary molecular diagnostics Industry Research

Product

PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits

INAAT Kits
Microarray Kits
DNA Sequencing Kits

Disease

Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

Species

Livestock Animals
- Porcine
- Poultry
- Bovine/Cattle
- Aquatic
- Ovine

Companion Animals
- Canine
- Feline
- Avian

End User

Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

1. Executive Summary

1.1. Global Veterinary Molecular Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

3.1. Global Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. PCR Kits
    - 3.1.1.1.1. RT-PCR Kits
    - 3.1.1.1.2. RAPD-PCR Kits
  - 3.1.1.2. INAAT Kits
  - 3.1.1.3. Microarray Kits
  - 3.1.1.4. DNA Sequencing Kits
3.2. Global Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Anaplasma spp.
  - 3.2.1.2. Ehrlichia spp.
  - 3.2.1.3. New Castle Disease
  - 3.2.1.4. Influenza
  - 3.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 3.2.1.6. Others
3.3. Global Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Livestock Animals
    - 3.3.1.1.1. Porcine
    - 3.3.1.1.2. Poultry
    - 3.3.1.1.3. Bovine/Cattle
    - 3.3.1.1.4. Aquatic
    - 3.3.1.1.5. Ovine
  - 3.3.1.2. Companion Animals
    - 3.3.1.2.1. Canine
    - 3.3.1.2.2. Feline
    - 3.3.1.2.3. Avian
3.4. Global Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Veterinary Hospitals
  - 3.4.1.2. Clinical Laboratories
  - 3.4.1.3. Veterinary Research Institutes
3.5. Global Veterinary Molecular Diagnostics Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

4.1. North America Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. PCR Kits
    - 4.1.1.1.1. RT-PCR Kits
    - 4.1.1.1.2. RAPD-PCR Kits
  - 4.1.1.2. INAAT Kits
  - 4.1.1.3. Microarray Kits
  - 4.1.1.4. DNA Sequencing Kits
4.2. North America Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Anaplasma spp.
  - 4.2.1.2. Ehrlichia spp.
  - 4.2.1.3. New Castle Disease
  - 4.2.1.4. Influenza
  - 4.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 4.2.1.6. Others
4.3. North America Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Livestock Animals
    - 4.3.1.1.1. Porcine
    - 4.3.1.1.2. Poultry
    - 4.3.1.1.3. Bovine/Cattle
    - 4.3.1.1.4. Aquatic
    - 4.3.1.1.5. Ovine
  - 4.3.1.2. Companion Animals
    - 4.3.1.2.1. Canine
    - 4.3.1.2.2. Feline
    - 4.3.1.2.3. Avian
4.4. North America Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Veterinary Hospitals
  - 4.4.1.2. Clinical Laboratories
  - 4.4.1.3. Veterinary Research Institutes
4.5. North America Veterinary Molecular Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.5.1.2. U.S. Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 4.5.1.3. U.S. Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 4.5.1.4. U.S. Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.5.1.5. Canada Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 4.5.1.6. Canada Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 4.5.1.7. Canada Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 4.5.1.8. Canada Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

5.1. Europe Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. PCR Kits
    - 5.1.1.1.1. RT-PCR Kits
    - 5.1.1.1.2. RAPD-PCR Kits
  - 5.1.1.2. INAAT Kits
  - 5.1.1.3. Microarray Kits
  - 5.1.1.4. DNA Sequencing Kits
5.2. Europe Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Anaplasma spp.
  - 5.2.1.2. Ehrlichia spp.
  - 5.2.1.3. New Castle Disease
  - 5.2.1.4. Influenza
  - 5.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 5.2.1.6. Others
5.3. Europe Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Livestock Animals
    - 5.3.1.1.1. Porcine
    - 5.3.1.1.2. Poultry
    - 5.3.1.1.3. Bovine/Cattle
    - 5.3.1.1.4. Aquatic
    - 5.3.1.1.5. Ovine
  - 5.3.1.2. Companion Animals
    - 5.3.1.2.1. Canine
    - 5.3.1.2.2. Feline
    - 5.3.1.2.3. Avian
5.4. Europe Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Veterinary Hospitals
  - 5.4.1.2. Clinical Laboratories
  - 5.4.1.3. Veterinary Research Institutes
5.5. Europe Veterinary Molecular Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.2. Germany Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.3. Germany Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.4. Germany Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.5. U.K. Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.6. U.K. Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.7. U.K. Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.8. U.K. Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.9. France Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.10. France Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.11. France Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.12. France Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.13. Italy Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.14. Italy Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.15. Italy Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.16. Italy Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.17. Turkey Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.18. Turkey Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.19. Turkey Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.20. Turkey Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.21. Russia Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.22. Russia Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.23. Russia Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.24. Russia Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

6.1. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. PCR Kits
    - 6.1.1.1.1. RT-PCR Kits
    - 6.1.1.1.2. RAPD-PCR Kits
  - 6.1.1.2. INAAT Kits
  - 6.1.1.3. Microarray Kits
  - 6.1.1.4. DNA Sequencing Kits
6.2. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Anaplasma spp.
  - 6.2.1.2. Ehrlichia spp.
  - 6.2.1.3. New Castle Disease
  - 6.2.1.4. Influenza
  - 6.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 6.2.1.6. Others
6.3. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Livestock Animals
    - 6.3.1.1.1. Porcine
    - 6.3.1.1.2. Poultry
    - 6.3.1.1.3. Bovine/Cattle
    - 6.3.1.1.4. Aquatic
    - 6.3.1.1.5. Ovine
  - 6.3.1.2. Companion Animals
    - 6.3.1.2.1. Canine
    - 6.3.1.2.2. Feline
    - 6.3.1.2.3. Avian
6.4. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Veterinary Hospitals
  - 6.4.1.2. Clinical Laboratories
  - 6.4.1.3. Veterinary Research Institutes
6.5. Asia Pacific Veterinary Molecular Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.2. China Veterinary Molecular Diagnostics Market Sample Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.3. China Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.4. China Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.5. Japan Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.6. Japan Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 6.5.1.7. Japan Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.8. Japan Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.9. South Korea Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.10. South Korea Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 6.5.1.11. South Korea Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.12. South Korea Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.13. India Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.14. India Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 6.5.1.15. India Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.16. India Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

7.1. Latin America Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. PCR Kits
    - 7.1.1.1.1. RT-PCR Kits
    - 7.1.1.1.2. RAPD-PCR Kits
  - 7.1.1.2. INAAT Kits
  - 7.1.1.3. Microarray Kits
  - 7.1.1.4. DNA Sequencing Kits
7.2. Latin America Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Anaplasma spp.
  - 7.2.1.2. Ehrlichia spp.
  - 7.2.1.3. New Castle Disease
  - 7.2.1.4. Influenza
  - 7.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 7.2.1.6. Others
7.3. Latin America Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Livestock Animals
    - 7.3.1.1.1. Porcine
    - 7.3.1.1.2. Poultry
    - 7.3.1.1.3. Bovine/Cattle
    - 7.3.1.1.4. Aquatic
    - 7.3.1.1.5. Ovine
  - 7.3.1.2. Companion Animals
    - 7.3.1.2.1. Canine
    - 7.3.1.2.2. Feline
    - 7.3.1.2.3. Avian
7.4. Latin America Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Veterinary Hospitals
  - 7.4.1.2. Clinical Laboratories
  - 7.4.1.3. Veterinary Research Institutes
7.5. Latin America Veterinary Molecular Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.2. Brazil Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 7.5.1.3. Brazil Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 7.5.1.4. Brazil Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.5. Mexico Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.6. Mexico Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 7.5.1.7. Mexico Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 7.5.1.8. Mexico Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.9. Argentina Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.10. Argentina Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 7.5.1.11. Argentina Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 7.5.1.12. Argentina Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, 2018 - 2031

8.1. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. PCR Kits
    - 8.1.1.1.1. RT-PCR Kits
    - 8.1.1.1.2. RAPD-PCR Kits
  - 8.1.1.2. INAAT Kits
  - 8.1.1.3. Microarray Kits
  - 8.1.1.4. DNA Sequencing Kits
8.2. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, by Disease, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Anaplasma spp.
  - 8.2.1.2. Ehrlichia spp.
  - 8.2.1.3. New Castle Disease
  - 8.2.1.4. Influenza
  - 8.2.1.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  - 8.2.1.6. Others
8.3. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, by Species, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Livestock Animals
    - 8.3.1.1.1. Porcine
    - 8.3.1.1.2. Poultry
    - 8.3.1.1.3. Bovine/Cattle
    - 8.3.1.1.4. Aquatic
    - 8.3.1.1.5. Ovine
  - 8.3.1.2. Companion Animals
    - 8.3.1.2.1. Canine
    - 8.3.1.2.2. Feline
    - 8.3.1.2.3. Avian
8.4. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Veterinary Hospitals
  - 8.4.1.2. Clinical Laboratories
  - 8.4.1.3. Veterinary Research Institutes
8.5. Middle East & Africa Veterinary Molecular Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.2. GCC Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 8.5.1.3. GCC Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 8.5.1.4. GCC Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.5. South Africa Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.6. South Africa Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 8.5.1.7. South Africa Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 8.5.1.8. South Africa Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.9. Egypt Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.10. Egypt Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 8.5.1.11. Egypt Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 8.5.1.12. Egypt Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.13. Nigeria Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.14. Nigeria Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 8.5.1.15. Nigeria Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 8.5.1.16. Nigeria Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Veterinary Molecular Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Veterinary Molecular Diagnostics Market by Disease, Value (US$ Mn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Veterinary Molecular Diagnostics Market by Species, Value (US$ Mn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Veterinary Molecular Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Species vs by Disease Heatmap
9.2. Manufacturer vs by Disease Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. bioMerieux SA
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. IDEXX Laboratories, Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Thermo Fisher Scientific Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Qiagen N.V.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Neogen Corporation
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. ID. Vet
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. INDICAL BIOSCIENCE GmbH
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Veterinary Molecular Diagnostics, Inc.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations